Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SOPH | Xu Zhenyu | Chief Scientific Officer | 13.10.2026 | Verkauf | 7,18 | 4.000 | 28.727 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 12.10.2026 | Verkauf | 7,26 | 5.000 | 36.303 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 12.10.2026 | Verkauf | 7,26 | 8.500 | 61.671 | Form 4 |
| SOPH | Van Well Daan | Chief Legal Officer | 05.10.2026 | Verkauf | 8,12 | 6.168 | 50.100 | Form 4 |
| SOPH | Valente Manuela | Chief People Officer | 05.10.2026 | Verkauf | 8,13 | 4.240 | 34.487 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 05.10.2026 | Verkauf | 8,12 | 5.284 | 42.929 | Form 4 |
| SOPH | Puylaert Kevin | Chief Sales Officer | 05.10.2026 | Verkauf | 7,92 | 31 | 246 | Form 4 |
| SOPH | Puylaert Kevin | Chief Sales Officer | 05.10.2026 | Verkauf | 8,06 | 185 | 1.491 | Form 4 |
| SOPH | Cardoza George | Chief Financial Officer | 05.10.2026 | Verkauf | 8,10 | 1.592 | 12.897 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 05.10.2026 | Verkauf | 8,13 | 7.394 | 60.100 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 05.10.2026 | Verkauf | 8,13 | 40.172 | 326.526 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 05.10.2026 | Verkauf | 8,12 | 7.394 | 60.075 | Form 4 |
| SOPH | Muken Ross | Chief Executive Officer | 05.10.2026 | Verkauf | 8,13 | 9.838 | 79.971 | Form 4 |
| SOPH | Cardoza George | Chief Financial Officer | 21.09.2026 | Verkauf | 8,33 | 774 | 6.447 | Form 4 |
| SOPH | Muken Ross | Chief Executive Officer | 21.09.2026 | Verkauf | 8,33 | 422 | 3.515 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 14.09.2026 | Verkauf | 7,88 | 5.000 | 39.417 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 14.09.2026 | Verkauf | 7,88 | 4.000 | 31.538 | Form 4 |
| SOPH | Van Well Daan | Chief Legal Officer | 11.09.2026 | Verkauf | 7,63 | 6.168 | 47.089 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 10.09.2026 | Verkauf | 7,66 | 8.500 | 65.120 | Form 4 |
| SOPH | Hibbs Kathy L | Director | 08.09.2026 | Verkauf | 8,13 | 6.250 | 50.818 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 27.08.2026 | Verkauf | 8,91 | 10.000 | 89.096 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 25.08.2026 | Verkauf | 8,68 | 5.000 | 43.397 | Form 4 |
| SOPH | Hibbs Kathy L | Director | 25.08.2026 | Verkauf | 8,68 | 6.250 | 54.233 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 24.08.2026 | Verkauf | 8,80 | 5.000 | 44.000 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 21.08.2026 | Verkauf | 8,40 | 5.408 | 45.447 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 20.08.2026 | Verkauf | 8,41 | 4.592 | 38.609 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 19.08.2026 | Verkauf | 8,20 | 5.000 | 41.000 | Form 4 |
| SOPH | Valente Manuela | Chief People Officer | 19.08.2026 | Verkauf | 7,94 | 10.000 | 79.439 | Form 4 |
| SOPH | Valente Manuela | Chief People Officer | 19.08.2026 | Optionsausübung | 3,20 | 10.000 | 32.000 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 19.08.2026 | Verkauf | 7,94 | 10.000 | 79.427 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 13.08.2026 | Verkauf | 7,52 | 4.000 | 30.076 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 12.08.2026 | Verkauf | 7,52 | 5.000 | 37.580 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 10.08.2026 | Verkauf | 7,61 | 8.500 | 64.669 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 07.08.2026 | Verkauf | 7,60 | 5.000 | 38.000 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 07.08.2026 | Verkauf | 7,23 | 20.000 | 144.540 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 07.08.2026 | Verkauf | 7,48 | 10.000 | 74.759 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 07.08.2026 | Verkauf | 7,02 | 7.000 | 49.152 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 07.08.2026 | Optionsausübung | 3,28 | 7.000 | 22.960 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 05.08.2026 | Verkauf | 7,00 | 3.000 | 21.013 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 05.08.2026 | Optionsausübung | 3,28 | 3.000 | 9.840 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 04.08.2026 | Verkauf | 6,95 | 5.000 | 34.772 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 04.08.2026 | Verkauf | 6,92 | 20.000 | 138.412 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 04.08.2026 | Verkauf | 6,92 | 10.000 | 69.168 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 27.07.2026 | Verkauf | 5,66 | 5.000 | 28.306 | Form 4 |
| SOPH | Jurgi Camblong | CEO | 20.04.2026 | Verkauf | 5,21 | 4.486 | 23.372 | Form 4 |
| SOPH | Kevin Puylaert | Insider | 20.04.2026 | Verkauf | 5,08 | 33 | 168 | Form 4 |
| SOPH | Manuela Valente | Insider | 20.04.2026 | Verkauf | 5,20 | 380 | 1.976 | Form 4 |
| SOPH | Philippe Menu | Insider | 20.04.2026 | Verkauf | 5,20 | 608 | 3.162 | Form 4 |
| SOPH | Ross Muken | President | 20.04.2026 | Verkauf | 5,20 | 760 | 3.952 | Form 4 |
| SOPH | Well Daan Van | Insider | 20.04.2026 | Verkauf | 5,20 | 684 | 3.557 | Form 4 |
| SOPH | Zhenyu Xu | Insider | 20.04.2026 | Verkauf | 5,21 | 608 | 3.168 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).